Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01598194 · ClinicalTrials.gov registry record · NA
Comparison of a Novel 22-gauge Core Biopsy Needle
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT01598194: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT01598194 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01598194, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to compare the performance of a newly available needle with reverse bevel design (called the EchoTip® Procore™ needle) with standard needles to see which needle gives better diagnostic information for pancreatic lesions.
Interventions
- DEVICE Novel 22-gauge Core Biopsy Needle + Standard Biopsy Needle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-01-30 |
| Est. Completion | 2017-07-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01598194
The ClinicalTrials.gov registry entry for NCT01598194 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Novel 22-gauge Core Biopsy Needle + Standard Biopsy Needle is the first listed.
NCT01598194 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01598194 about?
NCT01598194 is a clinical study titled "Comparison of a Novel 22-gauge Core Biopsy Needle". The goal of this clinical research study is to compare the performance of a newly available needle with reverse bevel design (called the EchoTip® Procore™ needle) with standard needles to see which needle gives better diagnostic information for pancreatic lesions.
What is the current status of trial NCT01598194?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-01-30. Estimated completion is 2017-07-06.
What interventions are being tested in trial NCT01598194?
The interventions under investigation include: Novel 22-gauge Core Biopsy Needle + Standard Biopsy Needle (DEVICE).
Who is sponsoring clinical trial NCT01598194?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.